To Prepare: Reflect On The Most Significant Talking Points ✓ Solved
To prepare: Reflect on the most significant talking points about
Reflect on the most significant talking points about the healthcare product or service solution you have proposed. These points should be those you think will educate decision makers and other stakeholders on the benefits of your idea as well as clarify the business case (including financial points, budgetary impacts, SWOT takeaways, cost-benefit analysis takeaways, etc.). Consider how you might highlight these significant talking points in an elevator speech to stakeholders. Start by writing a summary that defines major points you want to include in the elevator speech. This summary should be supported with scholarly references and properly formatted to meet the rubric standards.
Use the summary to identify significant talking points that you will use for your elevator speech. Post a 2- to 3-paragraph draft of an “elevator speech” designed to both educate and “sell” decision makers on the healthcare product or service you have proposed. Your elevator speech summary should address what you believe are the significant talking points necessary to educate decision makers and other stakeholders on the benefits of your idea as well as clarify the business case. Remember, an elevator speech should be approximately 30-60 seconds.
Paper For Above Instructions
The healthcare landscape is rapidly evolving, requiring innovative solutions to address persistent challenges such as rising costs, inefficiencies in service delivery, and disparities in access to care. The proposed healthcare solution, a telehealth service for chronic disease management, addresses these challenges effectively. The primary talking points to communicate to decision-makers include improved patient outcomes, cost-saving potential, and increased efficiency in healthcare delivery.
First and foremost, the telehealth solution enhances patient outcomes by providing continuous monitoring and timely interventions for individuals with chronic illnesses. A study by Greenhalgh et al. (2016) highlights how telehealth can reduce hospital admissions by allowing for proactive management of health conditions. This ability to monitor patients remotely empowers them to take charge of their health, leading to better disease control and improving overall quality of life. As healthcare providers embrace value-based care, demonstrating the effectiveness of telehealth in improving patient outcomes is crucial.
Furthermore, from a financial perspective, the proposed telehealth solution presents a significant cost-saving opportunity for healthcare organizations. According to a report by the American Hospital Association (2020), integrating telehealth can save hospitals up to $1.3 billion annually by reducing unnecessary emergency room visits and hospital admissions. Additionally, a cost-benefit analysis reveals that the initial investment in technology is outweighed by the long-term savings from reduced inpatient care and enhanced operational efficiency. This point is essential for decision-makers concerned about budgetary impacts, as it clarifies that investing in telehealth is not merely an expense but a strategic move that can enhance financial sustainability.
In preparing an elevator speech, it is vital to succinctly encapsulate these talking points. In a 30-60 second pitch, one might say: "Imagine a healthcare solution that not only improves patient outcomes but also saves costs for our organization. Our telehealth service for chronic disease management allows us to monitor patients in real-time, reducing hospital admissions by up to 25%, as highlighted in recent studies. As we shift towards value-based care, investing in telehealth not only enhances patient quality of life but also positions us strategically for financial success in the future. Let’s embrace this innovation to lead the way in effective healthcare delivery." This succinctly captures the essence of the proposed solution while addressing the interests of decision-makers regarding both benefits and business implications.
In conclusion, the proposed telehealth solution is poised to revolutionize chronic disease management by enhancing patient outcomes and providing significant economic benefits. Through continued advocacy and education around the efficacy and financial viability of this innovation, stakeholders can make informed decisions that support its implementation for the betterment of healthcare delivery.
References
- American Hospital Association. (2020). Telehealth: A path to a more sustainable future. Retrieved from https://www.aha.org
- Greenhalgh, T., Wherton, J., Papoutsi, C., et al. (2016). What matters to patients? A systematic review of patients' needs in telehealth. BMJ Open, 6(1), e009273. doi:10.1136/bmjopen-2015-009273
- Shah, S. R., et al. (2019). The impact of telehealth on the management of chronic diseases: A systematic review. American Journal of Managed Care, 25(8), 391-397. Retrieved from https://www.ajmc.com
- Trish, E. E., & Keenan, B. P. (2018). Telemedicine in the era of value-based care. Journal of Telemedicine and Telecare, 24(8), 503-510. doi:10.1177/1357633X18762349
- Scott, A. R., & Carver, S. (2017). Cost-effectiveness of telemedicine in chronic disease management: A scoping review. Health Policy, 121(3), 279-290. doi:10.1016/j.healthpol.2016.09.009
- Huang, F. W., et al. (2019). Telehealth utilization in prior authorization: A multi-state evaluation of outpatient utilization patterns. Healthcare, 7(4), 100-110. doi:10.3390/healthcare7040100
- Chumbler, N. R., et al. (2015). Telehealth and the measurement of health care costs: A review of the literature. Telemedicine and e-Health, 21(5), 370-375. doi:10.1089/tmj.2014.0022
- McCoy, L., et al. (2016). The evolving role of telehealth in chronic disease management. Journal of Nursing Scholarship, 48(4), 329-338. doi:10.1111/jnu.12175
- Fraser, J. T., & Marzola, C. D. (2021). Financial implications of telehealth in chronic diseases: A national survey. Telehealth Journal and e-Health, 27(12), 1415-1423. doi:10.1089/tmj.2021.0046